A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis [3]

Journal of Hepatology

Volumn 31, Issue 2, 1999, Pages 384-

  Basaranoglu, M ^a   Acbay, O ^a   Sonsuz, A ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GEMFIBROZIL; TRIACYLGLYCEROL;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LETTER; LIVER DISEASE; LIVER FUNCTION TEST; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032776856     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80243-8     Document Type: Letter

References (11)

1. OFW James CP Day Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance J Hepatol 29 1998 495 501
2. M Adler F Schaffner Fatty liver hepatitis and cirrhosis in obese patients Am J Med 67 1979 811 816
3. J Ludwig TR Viggiano DB McGill BJ Ott Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 1980 434 438
4. AM Diehl Z Goodman KG Ishak Alcohol-like liver disease in non-alcoholics. A clinical and histologic comparison with alcohol-induced liver injury Gastroenterology 95 1988 1056 1062
5. BR Bacon MJ Farahvash CG Janney BA Neuschwander-Tetri Nonalcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 1994 1103 1109
6. D Byron GY Minuk Profile of an urban hospital-based practice Hepatology 24 1996 813 815
7. J Laurin KD Lindor SJ Crippin A Gossard GJ Gores J Ludwig Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study Hepatology 23 1996 1464 1467
8. B Lombardi Considerations on the pathogenesis of fatty liver Lab Invest 15 1966 1 20
9. MU Dianzani Hepatotoxicology RG Meeks SD Harrison RJ Bull Biochemical Aspects of Fatty Liver 1991 CRC Boca Raton 327 399
10. AH Kissebah S Alfarsi PW Adams M Seed J Folkard V Wynn Transport kinetics of plasma free fatty acids, very low density lipoprotein triglycerides and apoprotein in patients with hypertriglyceridemia. Effects of 2,2-diemthyl, 5-(2,5-xylyloxy) valeric acid therapy Diabetologia 24 1976 199 218
11. YA Kesaniemi SM Grundy Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglyceride in man JAMA 251 1984 2241 2246